ナノ医療&ナノバイオテクノロジーの世界市場見通し2023年-2029年

◆英語タイトル:Nanomedicine and Nanobiotechnology Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書(MMG23FB0399)◆商品コード:MMG23FB0399
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2023年2月
◆ページ数:66
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のナノ医療&ナノバイオテクノロジー市場規模と予測を収録しています。・世界のナノ医療&ナノバイオテクノロジー市場:売上、2018年-2023年、2024年-2029年
・世界のナノ医療&ナノバイオテクノロジー市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のナノ医療&ナノバイオテクノロジー市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ナノ粒子」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ナノ医療&ナノバイオテクノロジーのグローバル主要企業は、Abbott、GE Healthcare、Johnson & Johnson、Merck、Pfizer、CombiMatrix、Celgene、Mallinckrodt、Sigma-Tau Pharmaceuticals、Teva Pharmaceutical、Nanosphere、UCB SAなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、ナノ医療&ナノバイオテクノロジーのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のナノ医療&ナノバイオテクノロジー市場:タイプ別、2018年-2023年、2024年-2029年
世界のナノ医療&ナノバイオテクノロジー市場:タイプ別市場シェア、2022年
・ナノ粒子、ナノシェル、ナノチューブ、ナノデバイス、その他

世界のナノ医療&ナノバイオテクノロジー市場:用途別、2018年-2023年、2024年-2029年
世界のナノ医療&ナノバイオテクノロジー市場:用途別市場シェア、2022年
・病院、診療所、研究所

世界のナノ医療&ナノバイオテクノロジー市場:地域・国別、2018年-2023年、2024年-2029年
世界のナノ医療&ナノバイオテクノロジー市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるナノ医療&ナノバイオテクノロジーのグローバル売上、2018年-2023年
・主要企業におけるナノ医療&ナノバイオテクノロジーのグローバル売上シェア、2022年
・主要企業におけるナノ医療&ナノバイオテクノロジーのグローバル販売量、2018年-2023年
・主要企業におけるナノ医療&ナノバイオテクノロジーのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Abbott、GE Healthcare、Johnson & Johnson、Merck、Pfizer、CombiMatrix、Celgene、Mallinckrodt、Sigma-Tau Pharmaceuticals、Teva Pharmaceutical、Nanosphere、UCB SA

*************************************************************

・調査・分析レポートの概要
ナノ医療&ナノバイオテクノロジー市場の定義
市場セグメント
世界のナノ医療&ナノバイオテクノロジー市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のナノ医療&ナノバイオテクノロジー市場規模
世界のナノ医療&ナノバイオテクノロジー市場規模:2022年 VS 2029年
世界のナノ医療&ナノバイオテクノロジー市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのナノ医療&ナノバイオテクノロジーの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のナノ医療&ナノバイオテクノロジー製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:ナノ粒子、ナノシェル、ナノチューブ、ナノデバイス、その他
ナノ医療&ナノバイオテクノロジーのタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、診療所、研究所
ナノ医療&ナノバイオテクノロジーの用途別グローバル売上・予測

・地域別市場分析
地域別ナノ医療&ナノバイオテクノロジー市場規模 2022年と2029年
地域別ナノ医療&ナノバイオテクノロジー売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Abbott、GE Healthcare、Johnson & Johnson、Merck、Pfizer、CombiMatrix、Celgene、Mallinckrodt、Sigma-Tau Pharmaceuticals、Teva Pharmaceutical、Nanosphere、UCB SA
...

This report aims to provide a comprehensive presentation of the global market for Nanomedicine and Nanobiotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanomedicine and Nanobiotechnology. This report contains market size and forecasts of Nanomedicine and Nanobiotechnology in global, including the following market information:
Global Nanomedicine and Nanobiotechnology Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Nanomedicine and Nanobiotechnology market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Nanoparticles Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nanomedicine and Nanobiotechnology include Abbott, GE Healthcare, Johnson & Johnson, Merck, Pfizer, CombiMatrix, Celgene, Mallinckrodt and Sigma-Tau Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nanomedicine and Nanobiotechnology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Nanomedicine and Nanobiotechnology Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Nanomedicine and Nanobiotechnology Market Segment Percentages, by Type, 2022 (%)
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Others
Global Nanomedicine and Nanobiotechnology Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Nanomedicine and Nanobiotechnology Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Research Institute
Global Nanomedicine and Nanobiotechnology Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Nanomedicine and Nanobiotechnology Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nanomedicine and Nanobiotechnology revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Nanomedicine and Nanobiotechnology revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
GE Healthcare
Johnson & Johnson
Merck
Pfizer
CombiMatrix
Celgene
Mallinckrodt
Sigma-Tau Pharmaceuticals
Teva Pharmaceutical
Nanosphere
UCB SA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nanomedicine and Nanobiotechnology, market overview.
Chapter 2: Global Nanomedicine and Nanobiotechnology market size in revenue.
Chapter 3: Detailed analysis of Nanomedicine and Nanobiotechnology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nanomedicine and Nanobiotechnology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Nanomedicine and Nanobiotechnology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nanomedicine and Nanobiotechnology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nanomedicine and Nanobiotechnology Overall Market Size
2.1 Global Nanomedicine and Nanobiotechnology Market Size: 2022 VS 2029
2.2 Global Nanomedicine and Nanobiotechnology Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nanomedicine and Nanobiotechnology Players in Global Market
3.2 Top Global Nanomedicine and Nanobiotechnology Companies Ranked by Revenue
3.3 Global Nanomedicine and Nanobiotechnology Revenue by Companies
3.4 Top 3 and Top 5 Nanomedicine and Nanobiotechnology Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nanomedicine and Nanobiotechnology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nanomedicine and Nanobiotechnology Players in Global Market
3.6.1 List of Global Tier 1 Nanomedicine and Nanobiotechnology Companies
3.6.2 List of Global Tier 2 and Tier 3 Nanomedicine and Nanobiotechnology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Nanomedicine and Nanobiotechnology Market Size Markets, 2022 & 2029
4.1.2 Nanoparticles
4.1.3 Nanoshells
4.1.4 Nanotubes
4.1.5 Nanodevices
4.1.6 Others
4.2 By Type – Global Nanomedicine and Nanobiotechnology Revenue & Forecasts
4.2.1 By Type – Global Nanomedicine and Nanobiotechnology Revenue, 2018-2023
4.2.2 By Type – Global Nanomedicine and Nanobiotechnology Revenue, 2024-2029
4.2.3 By Type – Global Nanomedicine and Nanobiotechnology Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Nanomedicine and Nanobiotechnology Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Research Institute
5.2 By Application – Global Nanomedicine and Nanobiotechnology Revenue & Forecasts
5.2.1 By Application – Global Nanomedicine and Nanobiotechnology Revenue, 2018-2023
5.2.2 By Application – Global Nanomedicine and Nanobiotechnology Revenue, 2024-2029
5.2.3 By Application – Global Nanomedicine and Nanobiotechnology Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Nanomedicine and Nanobiotechnology Market Size, 2022 & 2029
6.2 By Region – Global Nanomedicine and Nanobiotechnology Revenue & Forecasts
6.2.1 By Region – Global Nanomedicine and Nanobiotechnology Revenue, 2018-2023
6.2.2 By Region – Global Nanomedicine and Nanobiotechnology Revenue, 2024-2029
6.2.3 By Region – Global Nanomedicine and Nanobiotechnology Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Nanomedicine and Nanobiotechnology Revenue, 2018-2029
6.3.2 US Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.3.3 Canada Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.3.4 Mexico Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Nanomedicine and Nanobiotechnology Revenue, 2018-2029
6.4.2 Germany Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.4.3 France Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.4.4 U.K. Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.4.5 Italy Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.4.6 Russia Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.4.7 Nordic Countries Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.4.8 Benelux Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Nanomedicine and Nanobiotechnology Revenue, 2018-2029
6.5.2 China Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.5.3 Japan Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.5.4 South Korea Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.5.5 Southeast Asia Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.5.6 India Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Nanomedicine and Nanobiotechnology Revenue, 2018-2029
6.6.2 Brazil Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.6.3 Argentina Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Nanomedicine and Nanobiotechnology Revenue, 2018-2029
6.7.2 Turkey Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.7.3 Israel Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.7.4 Saudi Arabia Nanomedicine and Nanobiotechnology Market Size, 2018-2029
6.7.5 UAE Nanomedicine and Nanobiotechnology Market Size, 2018-2029
7 Nanomedicine and Nanobiotechnology Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Nanomedicine and Nanobiotechnology Major Product Offerings
7.1.4 Abbott Nanomedicine and Nanobiotechnology Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 GE Healthcare
7.2.1 GE Healthcare Company Summary
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Nanomedicine and Nanobiotechnology Major Product Offerings
7.2.4 GE Healthcare Nanomedicine and Nanobiotechnology Revenue in Global Market (2018-2023)
7.2.5 GE Healthcare Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Nanomedicine and Nanobiotechnology Major Product Offerings
7.3.4 Johnson & Johnson Nanomedicine and Nanobiotechnology Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Nanomedicine and Nanobiotechnology Major Product Offerings
7.4.4 Merck Nanomedicine and Nanobiotechnology Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Nanomedicine and Nanobiotechnology Major Product Offerings
7.5.4 Pfizer Nanomedicine and Nanobiotechnology Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 CombiMatrix
7.6.1 CombiMatrix Company Summary
7.6.2 CombiMatrix Business Overview
7.6.3 CombiMatrix Nanomedicine and Nanobiotechnology Major Product Offerings
7.6.4 CombiMatrix Nanomedicine and Nanobiotechnology Revenue in Global Market (2018-2023)
7.6.5 CombiMatrix Key News & Latest Developments
7.7 Celgene
7.7.1 Celgene Company Summary
7.7.2 Celgene Business Overview
7.7.3 Celgene Nanomedicine and Nanobiotechnology Major Product Offerings
7.7.4 Celgene Nanomedicine and Nanobiotechnology Revenue in Global Market (2018-2023)
7.7.5 Celgene Key News & Latest Developments
7.8 Mallinckrodt
7.8.1 Mallinckrodt Company Summary
7.8.2 Mallinckrodt Business Overview
7.8.3 Mallinckrodt Nanomedicine and Nanobiotechnology Major Product Offerings
7.8.4 Mallinckrodt Nanomedicine and Nanobiotechnology Revenue in Global Market (2018-2023)
7.8.5 Mallinckrodt Key News & Latest Developments
7.9 Sigma-Tau Pharmaceuticals
7.9.1 Sigma-Tau Pharmaceuticals Company Summary
7.9.2 Sigma-Tau Pharmaceuticals Business Overview
7.9.3 Sigma-Tau Pharmaceuticals Nanomedicine and Nanobiotechnology Major Product Offerings
7.9.4 Sigma-Tau Pharmaceuticals Nanomedicine and Nanobiotechnology Revenue in Global Market (2018-2023)
7.9.5 Sigma-Tau Pharmaceuticals Key News & Latest Developments
7.10 Teva Pharmaceutical
7.10.1 Teva Pharmaceutical Company Summary
7.10.2 Teva Pharmaceutical Business Overview
7.10.3 Teva Pharmaceutical Nanomedicine and Nanobiotechnology Major Product Offerings
7.10.4 Teva Pharmaceutical Nanomedicine and Nanobiotechnology Revenue in Global Market (2018-2023)
7.10.5 Teva Pharmaceutical Key News & Latest Developments
7.11 Nanosphere
7.11.1 Nanosphere Company Summary
7.11.2 Nanosphere Business Overview
7.11.3 Nanosphere Nanomedicine and Nanobiotechnology Major Product Offerings
7.11.4 Nanosphere Nanomedicine and Nanobiotechnology Revenue in Global Market (2018-2023)
7.11.5 Nanosphere Key News & Latest Developments
7.12 UCB SA
7.12.1 UCB SA Company Summary
7.12.2 UCB SA Business Overview
7.12.3 UCB SA Nanomedicine and Nanobiotechnology Major Product Offerings
7.12.4 UCB SA Nanomedicine and Nanobiotechnology Revenue in Global Market (2018-2023)
7.12.5 UCB SA Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ナノ医療&ナノバイオテクノロジーの世界市場見通し2023年-2029年(Nanomedicine and Nanobiotechnology Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。